The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A highly transmissible new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading in the United States, CDC data show.

Who is being left behind? – herald Tawanda Musarurwa Check Point Desk “EVEN when people know about HIV and take risks, there are still many reasons why some men might not go for testing. “Sometimes it ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Around 1.2 million U.S. adults are living with HIV, but about 13 percent don’t know they have it. Knowing your HIV status can lead to earlier treatment. It can also help prevent HIV from ...

gInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA hDivision of AIDS, National Institute of Allergy and Infectious Diseases, ...